Hedera Dx

Epalinges, Switzerland

A diagnostics platform that makes liquid biopsies a reality in cancer care

$17.1M raised

May 2025

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Hedera Dx raised?

Hedera Dx has raised $17.1M in total funding. The most recent round was Series A. The last funding was announced in May 2025.

Who are Hedera Dx's investors?

Hedera Dx's investors include Vsquared Ventures, Inventure, Tesi, Air Street Capital, GRIDS Capital.

Where is Hedera Dx headquartered?

Hedera Dx is headquartered in Epalinges, Switzerland.

What does Hedera Dx do?

A diagnostics platform that makes liquid biopsies a reality in cancer care

What stage is Hedera Dx at?

Hedera Dx is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 27, 2025.

MLA

"Hedera Dx — Funding & Investors." VCBacked, May 27, 2025, https://www.vcbacked.co/company/hedera-dx. Accessed July 7, 2026.

APA

VCBacked. (2025). Hedera Dx — Funding & Investors. Retrieved July 7, 2026, from https://www.vcbacked.co/company/hedera-dx

Wikipedia (cite web)

{{cite web |title=Hedera Dx — Funding & Investors |url=https://www.vcbacked.co/company/hedera-dx |website=VCBacked |access-date=July 7, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 27, 2025.